107 related articles for article (PubMed ID: 2886098)
1. Is dopamine related to immunologic changes in schizophrenic patients?
Kerepcić I; Bamburac J; Jurin M
Ann N Y Acad Sci; 1987; 496():737-9. PubMed ID: 2886098
[No Abstract] [Full Text] [Related]
2. The effects of typical and atypical neuroleptics on mitogen-induced T lymphocyte responsiveness.
Rapaport MH; McAllister CG; Kirch DG; Pickar D
Biol Psychiatry; 1991 Apr; 29(7):715-7. PubMed ID: 1711382
[No Abstract] [Full Text] [Related]
3. [Schizophrenia and immunity].
Galinowski A; Levy-Soussan P; Lôo H
Ann Med Psychol (Paris); 1992; 150(2-3):138-42. PubMed ID: 1364190
[TBL] [Abstract][Full Text] [Related]
4. [Changes in the functional activity of T-lymphocytes after administration of stelazine].
Androsova LV; Sekirina TP
Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(8):87-9. PubMed ID: 1684460
[TBL] [Abstract][Full Text] [Related]
5. T lymphocytes in schizophrenia.
Coffey CE; Sullivan JL; Rice JR
Biol Psychiatry; 1983 Jan; 18(1):113-9. PubMed ID: 6131701
[No Abstract] [Full Text] [Related]
6. T-cells and psychopathology in schizophrenia: relationship to the outcome of neuroleptic therapy.
Müller N; Hofschuster E; Ackenheil M; Eckstein R
Acta Psychiatr Scand; 1993 Jan; 87(1):66-71. PubMed ID: 8093825
[TBL] [Abstract][Full Text] [Related]
7. The role of immune function in schizophrenia: an overview.
Müller N; Riedel M; Ackenheil M; Schwarz MJ
Eur Arch Psychiatry Clin Neurosci; 1999; 249 Suppl 4():62-8. PubMed ID: 10654111
[TBL] [Abstract][Full Text] [Related]
8. [Peripheral blood T-lymphocyte and T-lymphocyte subset ratios before and after treatment in schizophrenia patients not taking antipsychotic medication].
Baskak SC; Ozsan H; Baskak B; Devrimci Ozgüven H; Kinikli G
Turk Psikiyatri Derg; 2008; 19(1):5-12. PubMed ID: 18330738
[TBL] [Abstract][Full Text] [Related]
9. Stimulated lymphocytes in schizophrenia.
Hirata-Hibi M; Higashi S; Tachibana T; Watanabe N
Arch Gen Psychiatry; 1982 Jan; 39(1):82-7. PubMed ID: 6119967
[TBL] [Abstract][Full Text] [Related]
10. [Clinical and experimental research of immunomodulatory effect of amisulpride].
Vetlugina TP; Lobacheva OA; Al'perina EL; Zhukova EN; Semke AV; Nikitina VB; Cheĭdo MA; Idova GV
Vestn Ross Akad Med Nauk; 2012; (12):13-7. PubMed ID: 23530420
[TBL] [Abstract][Full Text] [Related]
11. New insights into schizophrenia through atypical antipsychotic drugs.
Meltzer HY
Neuropsychopharmacology; 1988 Sep; 1(3):193-6. PubMed ID: 2908017
[No Abstract] [Full Text] [Related]
12. An un-dopamine hypothesis of schizophrenia.
Alpert M; Friedhoff AJ
Schizophr Bull; 1980; 6(3):387-9. PubMed ID: 6105705
[TBL] [Abstract][Full Text] [Related]
13. Dopamine and its relation to schizophrenia and antipsychotic drugs.
Tarnoff GM
Bull Menninger Clin; 1978 Jul; 42(4):321-38. PubMed ID: 29683
[No Abstract] [Full Text] [Related]
14. Effects of psychoactive drugs on in vitro lymphocyte activation.
Ferguson RM; Schmidtke JR; Simmons RL
Birth Defects Orig Artic Ser; 1978; 14(5):379-405. PubMed ID: 210858
[No Abstract] [Full Text] [Related]
15. Tolerance to phenothiazines in schizophrenic patients.
Malek-Ahmadi P; Chapel JL
Gen Pharmacol; 1976 Dec; 7(6):377-9. PubMed ID: 14052
[No Abstract] [Full Text] [Related]
16. Dopamine, the prefrontal cortex and schizophrenia.
Knable MB; Weinberger DR
J Psychopharmacol; 1997; 11(2):123-31. PubMed ID: 9208376
[TBL] [Abstract][Full Text] [Related]
17. The behavior of T lymphocytes in schizophrenia.
Liedeman RR; Prilipko LL
Birth Defects Orig Artic Ser; 1978; 14(5):365-77. PubMed ID: 308380
[No Abstract] [Full Text] [Related]
18. Enhancement of immune response by phenothiazine administration in vivo.
Ghosh N; Chattopadhyay U
In Vivo; 1993; 7(5):435-40. PubMed ID: 7906554
[TBL] [Abstract][Full Text] [Related]
19. COX-2 inhibition as a treatment approach in schizophrenia: immunological considerations and clinical effects of celecoxib add-on therapy.
Müller N; Ulmschneider M; Scheppach C; Schwarz MJ; Ackenheil M; Möller HJ; Gruber R; Riedel M
Eur Arch Psychiatry Clin Neurosci; 2004 Feb; 254(1):14-22. PubMed ID: 14991374
[TBL] [Abstract][Full Text] [Related]
20. Psychotogenic drugs as models for schizophrenia.
Snyder SH
Neuropsychopharmacology; 1988 Sep; 1(3):197-9. PubMed ID: 2908018
[No Abstract] [Full Text] [Related]
[Next] [New Search]
